Request to Join
has invited you to join this group
John is a Cardiovascular Surgeon with thirty years of experience in multiple settings; private practice and academic medicine, and has worked in both solo and group practice environments. He holds a Masters Degree in Education concentrating in Policy, Planning, and Administration and a certificate in Values Based Coaching, both from Boston University. John has experience working with individuals and organizations addressing the challenges they face functioning in dynamically changing environments. He has experience as an administrator working as an Assistant Dean of a School of Medicine where he coaches medical students to successful lives and careers in medicine. His coaching strategy focuses on setting goals, creating outcomes and managing personal and organizational change. He uses evidence-based coaching strategies grounded in Positive Psychology, Appreciative Inquiry, Motivational Interviewing and Mindfulness. He enjoys providing professional coaching to individuals and organizations that find themselves challenged by issues which interfere with their ability to experience continued growth and development. John enjoys a full and balanced life with family and friends, work, and an eclectic group of recreational activities. He believes that life is a journey of learning, growth and development.
Dr. Keith D. Lillemoe received his undergraduate education at the University of South Dakota and his MD from The Johns Hopkins University School of Medicine in l978. He served his entire surgical training at The Johns Hopkins Hospital from l978 to l985. He joined the faculty at Hopkins in l985 and rose to the rank of Professor of Surgery in l996. He served as Associate Program Director for the Hopkins Surgical Residency from l993 to 2003 and Vice-Chairman and Deputy Director of the department from l997 to 2003. During his time at Johns Hopkins, he was recognized with the Department of Surgery Faculty Teaching Award on five occasions. In September 2003 he was appointed the Jay L. Grosfeld Professor and Chairman of the Department of Surgery at the Indiana University School of Medicine. He also served as the Program Director of their general surgery residency. In May 2011, Dr. Lillemoe was appointed to the position of Surgeon-in- Chief and Chief of the Department of Surgery at the Massachusetts General Hospital in Boston and the W. Gerald Austen Professor of Surgery at the Harvard Medical School. Dr. Lillemoe is a member of most surgical societies and has held office in many. He has served as Secretary, President and Chairman of the Board of Trustees of the Society for Surgery of the Alimentary Tract. He has previously served as President of the Society of Clinical Surgery, Secretary and President of the Society of University Surgeons, and President of the Halsted Society. He has served as the Recorder and is the current President of the American Surgical Association. Dr. Lillemoe is a Senior Director of the American Board of Surgery. In April of 2015 Dr. Lillemoe was inducted into the Johns Hopkins Society of Scholars. In October 2017, he will be recognized with the Honorary Member Award of the Award of the Association of Women’s Surgeons. Dr. Lillemoe’s research interests have ranged from basic science investigations into the pathophysiology of gallstones and other benign biliary tract disease to the clinical management of pancreatic carcinoma and bile duct injuries. He has been funded in the past by the National Institute of Health and with numerous grants from industry. His bibliography lists over 420 journal articles and 130 book chapters. He has served as a visiting professor over 110 times and has spoken nationally and internationally on over 450 occasions. He is currently the Editor of one of the leading surgical texts Surgery: Scientific Principles and Practice and is Editor-in- Chief of Annals of Surgery. Dr. Lillemoe’s clinical interests are in gastrointestinal and pancreaticobiliary tract surgery. He has contributed to major advances in the management of pancreatic cancer, bile duct injuries and strictures, and numerous other abdominal conditions. In recent years his research interests have included surgical education, patient safety, quality and health care disparities.
Jason received his medical degree from the University of Illinois at Chicago. He completed an Internal Medicine internship and residency at UCLA, and joined the UCLA faculty in 2005. He is board certified in Internal Medicine and Palliative Care. He currently serves as Associate Director of the UCLA Hospitalist Service based at the Ronald Reagan Medical Center, Co-Director of Human Biology and Diseases Course 409 (renal, cardiac and pulmonary pathophysiology) for the David Geffen School of Medicine at UCLA, and Co-Chair of the UCLA Acute Care College for fourth-year medical students. He serves as a core faculty member for the UCLA Internal Medicine residency program. His interests include medical student and resident education and advising, medical simulation, the physical examination, and diagnostic dilemmas.
Dr. Megan Young is an Assistant Professor of Medicine in the Section of Geriatrics at Boston University School of Medicine (BUSM). She received her MD degree from the University of Chicago Pritzker School of Medicine. She then went on to complete a primary care residency in Internal Medicine at Boston Medical Center and a clinician-educator fellowship in Geriatrics at Boston University. She is currently an Assistant Dean in the office of student affairs and the course director for one of the doctoring courses at BUSM. She has also served as the assistant clerkship director for the 4th year geriatrics ambulatory clerkship. She is the faculty advisor for the geriatric student interest group. Clinically she provides home base primary care to frail elders in the community surrounding Boston Medical Center.
Dr. Oscar Salvatierra is Professor of Surgery and Pediatrics, Emeritus, and former Advising Dean at the Stanford University School of Medicine. He obtained his B.S. from Georgetown University, his M.D. from the University of Southern California, did a urology/surgery residency at USC-LA County Medical Center and a transplant surgery fellowship at UCSF. Most of his professional career has been spent at UCSF (Chief, Transplant Service) and Stanford University (Director, Pediatric Kidney Transplantation). He has over 300 publications in the medical literature which include: introduction of universally previously forbidden pre-transplant donor-specific blood transfusions (DSTs); characterization of hemodynamic, morphologic and genetic changes with the transplantation of adult-sized kidneys (ASKs) into infants and small children with resultant very high graft survival rates; demonstration of long-term immunologic protection of ASKs transplanted into infants; introduction of complete steroid-free immuno-suppression for children; development of management strategies for severe congenital structural abnormalities of the urinary tract followed by transplantation. Dr. Salvatierra has served as President of 5 national and international transplant professional societies, including the American Society of Transplant Surgeons (ASTS). The Transplantation Society, and the United Network of Organ Sharing (UNOS). He worked 2 years with former Vice President Albert Gore to draft the National Organ Transplant Act (NOTA), which established the infrastructure of the U.S. organ transplantation system, authorized the creation of regional Organ Procurement Organizations (OPOs), and provided for a central National Registry for ongoing evidence-based research and future policy direction. NOTA also provided for the beginning of a national Bone Marrow Registry. This is the only time that Congress has enacted legislation to establish the framework for the infrastructure of a medical specialty. NOTA thus provides for a unique private/public partnership that has brought together 257 autonomously operating transplant centers under the UNOS umbrella and is further operationally bolstered by 58 regional OPOs. This organizational structure has collectively assured fiduciary responsibility to protect all donated organs for the public to which they belong, and has functionally promoted maximum utilization and equitable distribution of all organs for transplantation. Dr. Salvatierra chaired the NIH National Advisory Board for kidney and urologic research. He was the first Governor elected to represent organ transplantation in the American College of Surgeons. He chaired the Stanford Medical School Faculty Senate. He was the Faculty Leader for the successful 2005 8-year LCME recertification process for the Stanford University Medical School. He introduced Pope John Paul II for his encyclical on organ transplantation and donation in Rome in the year 2000. Dr. Salvatierra’s honors include: Knighthood by the Republic of Italy, the Presidential Medal from the President of Argentina, a Special Commendation Resolution by the California State Legislature, the UCSF Chancellor’s Award for Public Service, a Special Recognition Award by the UCSF Chancellor, Stanford’s Rambar-Mark Award as Clinician of the Year and Stanford’s Franklin Ebaugh Award for Medical Student Advising. Stanford’s Oscar Salvatierra Annual Lectureship in Transplantation has been named after him. He was the winner of the 2007 Albion Walter Hewlett Award, Stanford’s highest award for a clinician-scientist, for being the “epitome of the academician dedicated to discovery in the biological sciences and to the sensitive and scientific application of such new knowledge in the effective treatment of human disease.” He was only the 5th surgeon to receive this award since its inception in 1983. He is also the recipient of the 2016 Pioneer Award, the highest honor bestowed by the ASTS. He was also awarded the National Kidney Foundation’s Lifetime Champion of Hope Award. On the 50th anniversary of the first successful organ transplant, he was named one of 12 International Pioneers in Transplantation. He has been listed in Who’s Who in America and Who’s Who in the World. He served in the U.S. Army as a urologist/surgeon in the Vietnam War, was a volunteer surgeon at a Vietnamese hospital treating Vietnamese war victims and was subsequently appointed by the U.S. Federal Court to the National Advisory Board that administered the Agent Orange litigation settlement.
Colonel(CA) Ronit Katz M.D emigrated from Israel in 1982 she received her medical degree magna cum laude, completed a fellowship in cancer research at Tufts-New England Medical Center, and later was appointed a Faculty Member at Harvard University School of Public Health. She is Board Certified in Preventive, Occupational and Environmental Medicine, and is a Fellow of the American College of Preventive Medicine. She was the recipient of Lawrence Livermore National Lab's (LLNL) “Certificate of Excellence” for outstanding performance in support of the Health Services Department and was elected as President of LLNL Women’s Association. In 2007, Dr Katz received The American Medical Association’s “Excellence in Medicine and Leadership Award”. In 2013, Dr Katz received the prestigious " NASA Group Achievement Award" for her role in the NASA- AMES Human Performance Centrifuge Project Team.
"In 4/ 2018 Professor Ronit Katz served as a Keynote Speaker at the Disaster Preparedness part of an International Conference on Bio-terrorism and Counter-terrorism in Tokyo,Japan.The Conference ,organized by the Japan Medical Association is an Extremely prestigious and renowned event that attracts Japanese Cabinet members among others. Professor katz spoke on Overview and Medical Response to CBRNE ( Chemical Biological Radiological Nuclear Explosives )"
She serves on many Boards and Committees for local and national professional organizations, among them Bay Area Air Quality Management,Medical Director(Act.)at Stanford University Medical Center, Judge for the AMA Research Symposium, AMA-IMG Scientific Committee, AMA-IMG Nominating Committee, Chair of the AMA-IMG Leadership Development Committee, and Chair of the AMA-IMG Governing Council. Currently, she is Clinical Associate Professor at Stanford University Medical Center, where she treats patients and teaches new doctors and medical students, and an Occupational& Environmental Medicine Expert for the War Related Injury and Illness Study Center (WRIISC) at the Palo Alto VA Hospital. Colonel katz continue to serve as a AMA-IMG Governing Council Member and was selected from Stanford University Medical Center to be the Stanford-OMSS Representative to the AMA.
Dr. Ajay K. Singh is Senior Associate Dean for Global and Continuing Education at Harvard Medical School and Director, Master in Medical Sciences in Clinical Investigation (MMSCI) Program. He leads a vibrant group of faculty and staff in developing and overseeing postgraduate medical education at HMS, as well as the Master's program in Clinical Investigation. He has been Executive Director for the Dubai Harvard Foundation of Medical Research since 2008. Dr. Singh completed his undergraduate and medical training in England at University College London School of Medicine. He moved to Boston in 1987 for his clinical and research renal fellowship at Tufts-New England Medical Center, which he finished in 1992, when he joined the Tufts University faculty. In 1998 he moved to the Brigham and Women’s Hospital — one of the principal teaching hospitals of Harvard Medical School — as Clinical Director of the Renal Division and Director, Dialysis Services and Associate Professor of Medicine at HMS. In 2008 he became Chief Academic Officer and Executive Director, Dubai Harvard Foundation for Medical Research (DHFMR). Dr. Singh’s interests are in clinical research – with a particular focus on the anemia of chronic kidney disease. He led groundbreaking studies in anemia of kidney disease, including the CHOIR study, which was published in the New England Journal of Medicine, and well as being a member of the steering committees for the TREAT and DRIVE studies. More recently, he has taken on the role of leading the ASCEND Clinical development program - a phase 3 program for the development of a novel propel hydroxyls inhibitor Daprodustat. Dr. Singh is currently Editor-in-Chief of Scientific American Medicine and also Chair of the Editorial Board for Nephrology Times. He leads the office of Postgraduate Medical Education at the Brigham and Women's Hospital and in this capacity leads several HMS CME courses. He is the author of over 150 original contributions and review articles, as well as author/editor of 11 books in in internal medicine and nephrology. Dr. Singh is a Fellow of the Royal College of Physicians in London, and has an MBA from Boston University.
Iljie Fitzgerald, M.D, M.S, is an Assistant Dean for Student Affairs and an Assistant Clinical Professor of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at the University of California, Los Angeles. She completed her undergraduate education at the California Institute of Technology and medical school at the University of California, San Francisco. Along the way, she also earned her Master’s degree in Health and Medical Sciences in the University of California, Berkeley/University of California, San Francisco Joint Medical Program. After her residency, including a chief resident year, in psychiatry at UCSF, she joined the faculty of the David Geffen School of Medicine at UCLA in 2010. She is a very active and enthusiastic clinician-educator at DGSOM, and her passion is helping and guiding learners at all levels reach their highest potential in pursuit of their goals. She finds great fulfillment and meaning in her clinical work in a public hospital setting, and has been recognized at UCLA and nationally for her educational and humanistic strengths and leadership.